Valuation: EMVision Medical Devices Ltd

Market Cap 167M 119M 102M 94.9M 87.08M 164M 11.37B 1.13B 439M 5.7B 446M 436M 18.86B P/E 2026 *
-18.3x
P/E 2027 * -15.9x
Enterprise Value 167M 119M 102M 94.9M 87.08M 164M 11.37B 1.13B 439M 5.7B 446M 436M 18.86B EV / Sales 2026 *
30.3x
EV / Sales 2027 * 33.4x
Free-Float
66.78%
Yield 2026 *
-
Yield 2027 * -
1 week+1.13%
Current month+12.54%
1 month+9.45%
3 months+9.12%
6 months+1.13%
Current year+0.84%
1 week 1.7
Extreme 1.7
1.86
1 month 1.5
Extreme 1.5
1.86
Current year 1.47
Extreme 1.47
1.96
1 year 1.47
Extreme 1.47
2.43
3 years 1.37
Extreme 1.37
2.72
5 years 1.13
Extreme 1.13
3.35
10 years 0.28
Extreme 0.28
4.2
Manager TitleAgeSince
Chief Executive Officer - 2023-06-30
Director of Finance/CFO - 2026-01-31
Chief Tech/Sci/R&D Officer - 2023-06-30
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - 2018-06-30
Date Insider Type Main position Quantity % Market Cap.
1/2/26 Expiration

Chairman

300,000 0.3228%
11/18/25 Free

Director

200,000 0.2176%
11/20/24 Free

Director

200,000 0.2339%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+1.13%-0.28%+32.47% 119M
+2.28%+5.31%+26.83%+17.88% 227B
+2.09%+5.90%+2.13%-14.12% 149B
-5.84%-6.68%-22.06%+30.96% 141B
-5.08%-4.49%-53.45%-1.63% 75.37B
-2.65%-2.95%+10.37%+17.30% 53.19B
-0.43%+1.97%-17.34%-12.52% 51.88B
+0.57%+4.70%+31.22%+31.07% 43.89B
-2.68%-2.13%+36.38%+49.89% 40.86B
-0.75%+0.37%+0.26%+8.34% 33.7B
Average +0.13%+0.64%+1.41%+15.96% 81.51B
Weighted average by Cap. +0.98%+1.22%+2.20%+12.44%

Financials

2026 *2027 *
Net sales 5.5M 3.92M 3.35M 3.13M 2.87M 5.39M 375M 37.11M 14.47M 188M 14.7M 14.38M 622M 5M 3.56M 3.05M 2.84M 2.61M 4.9M 341M 33.74M 13.15M 171M 13.37M 13.08M 565M
Net income -9.1M -6.48M -5.55M -5.18M -4.75M -8.92M -620M -61.4M -23.94M -311M -24.33M -23.8M -1.03B -12M -8.54M -7.32M -6.83M -6.26M -11.77M -818M -80.97M -31.56M -410M -32.08M -31.38M -1.36B
Net Debt - -
Logo EMVision Medical Devices Ltd
EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.
Employees
-
Date Price Change Volume
26-08-20 A$1.795 0.00% 11,187
26-08-20 A$1.795 -0.55% 40,658
26-08-19 A$1.805 +1.98% 54,545
26-08-18 A$1.770 +1.14% 25,723
26-08-17 A$1.750 -1.41% 17,894
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.795AUD
Average target price
3.150AUD
Spread / Average Target
+75.49%

Annual profits - Rate of surprise